Press Releases
4 hours ago
Cybersecurity Market Surges to $351.92 billion by 2030 | CAGR 9.1%
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
Finnish MP Gets Convicted for Pamphlet Deemed Offensive to Gay People
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Apr. 1, 2026
Deafmetal Opens Seed Round and Launches Audiology Clinic Program to Scale Hearing Aid Jewelry Globally
Neutral
EIN Presswire
Jan. 1, 1970
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
Global Health Leaders to Convene in London for Inaugural International Case Management Conference
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
Indeterminate
GlobeNewswire, Inc.
Apr. 8, 2026
Brisbane Surgeons Publish World-First Nomogram for Corneal Ring Segment Treatment of Keratoconus
Neutral
EIN Presswire
Jan. 1, 1970
Sauna bathing may boost immune responses
Indeterminate
GlobeNewswire, Inc.
Apr. 8, 2026
Power Generator Rental Market Size, Share & Forecast 2026–2032 | USD 4.06 Bn Growing at 5.1% CAGR
Neutral
EIN Presswire
Jan. 1, 1970
Rover Reveals How Americans Are Redefining Pet Parenthood Across Generations
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Indeterminate
GlobeNewswire, Inc.
Jan. 1, 1970
GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression
Indeterminate
GlobeNewswire, Inc.